Optimizing risks and benefits of dual antiplatelet therapy after ACS: a winding path to precision [0.03%]
ACS后双联抗血小板治疗的利弊优化：精准之路任重道远
Antonio Landi,Diana A Gorog
Antonio Landi
Plasma expression of lncRNA Wisper in patients with heart failure and patients with myocardial infarction [0.03%]
心力衰竭和心肌梗死患者血浆Wisper长链非编码RNA的表达
Jordanka G Doneva,Veselin D Valkov,Ivan S Donev et al.
Jordanka G Doneva et al.
Background: Heart failure (HF) and ST-elevation myocardial infarction (STEMI) are the major causes of morbidity and mortality worldwide. Recent evidence indicates that long noncoding RNAs (lncRNAs) participate in cardiac ...
Navigating the emerging landscape of asymptomatic ATTR-CM: challenges, opportunities and the path ahead [0.03%]
无症状ATTR心肌病新兴领域的挑战、机遇及未来之路
Aldostefano Porcari
Aldostefano Porcari
Transthyretin amyloid cardiomyopathy (ATTR-CM) has long been considered a rare and inexorably fatal condition. However, advances in noninvasive diagnosis, disease awareness, and available treatments have enabled diagnosis in asymptomatic st...
Cross-pollination of two specialties: potential repurposing of cancer and cardiovascular drugs for the benefit of the other [0.03%]
两种专科的交叉研究：癌症和心血管药物再利用的潜在益处
Orly Leiva,Jeanne M DeCara,Eric H Yang et al.
Orly Leiva et al.
Despite advancements in treatment, cancer and cardiovascular disease remain the leading causes of morbidity and mortality in developed nations. Cancer therapies have led to improved cancer-specific outcomes at the potential risk of cardioto...
A real-world study of tafamidis in people with transthyretin amyloid cardiomyopathy (ATTR-CM) with heart and nerve symptoms: a plain language summary [0.03%]
Tafamidis治疗转甲状腺素蛋白淀粉样变性心肌病（ATTR-CM）患者的现实世界研究：简易版报告
Jonas Wixner,Angela Dispenzieri,Leslie Amass et al.
Jonas Wixner et al.
Prognostic value of chronic ECG changes in patients undergoing hemodialysis [0.03%]
血液透析患者的慢性心电图变化的预后价值
Chloe Kharsa,Roy Chlawit,Mabel Aoun
Chloe Kharsa
Background: Patients on maintenance hemodialysis (HD) face high cardiovascular (CV) mortality risk. Although electrocardiograms (ECGs) are routinely performed, the prognostic significance of chronic ECG abnormalities in p...
Impact of heart failure on in-hospital outcomes of pulmonary valve interventions: a nationwide analysis [0.03%]
心力衰竭对肺瓣膜介入治疗院内预后影响的全国范围分析
Mohammad Ali Sheffeh,Heena Asnani,Ider Oujamaa et al.
Mohammad Ali Sheffeh et al.
Background: Data on outcomes of surgical pulmonary valve replacement or repair (SPVR/SPVr) in patients with heart failure (HF) are limited. We aimed to assess the safety and complications of SPVR/SPVr in this population. ...
Prognostic value of the endothelial activation and stress index score for short- and long-term outcomes in critically ill infective endocarditis patients [0.03%]
重症感染性心内膜炎患者短期和长期预后不良的血管内皮激活与应激指数评分预测价值
Ya-Chun Chen,Bin Zhan,Feng-Qin Fu et al.
Ya-Chun Chen et al.
Background: Endothelial dysfunction drives infective endocarditis (IE) pathogenesis, yet prognostic biomarkers for critically ill IE patients remain scarce. We assessed the Endothelial Activation and Stress Index (EASIX) ...
The importance of a patient-tailored approach to surgical aortic valve replacement [0.03%]
外科主动脉瓣置换的个体化治疗的重要性
Massimo Baudo,Dimitrios E Magouliotis,Basel Ramlawi
Massimo Baudo
The interaction between inflammatory bowel disease and cardiovascular disease: what we know [0.03%]
炎症性肠病和心血管疾病之间的相互作用：我们所了解的
Gabriel Chodick,Noa Cohen-Heyman
Gabriel Chodick
Inflammatory bowel disease (IBD) has emerged as a significant risk factor for cardiovascular disease (CVD). Despite shared pathophysiological mechanisms including chronic inflammation, immune dysregulation, and endothelial dysfunction, the ...